Quest Diagnostics Inc (Quest Diagnostics) is a healthcare company engaged in providing diagnostic information services to patients and physicians through a network of laboratories and company-owned patient service centers. It offers an array of services, including clinical testing with gene-based and other esoteric tests, anatomic pathology services, clinical trial testing, life insurer services, and various healthcare information technology and diagnostic products. The company's products and services are utilized by physicians, hospitals, patients, health plans, and government agencies across various healthcare sectors. Quest Diagnostics operates through a network of laboratories and patient service centers. The company has operations in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Secaucus, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Report Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Quest Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Quest Diagnostics Inc Company Overview
- Quest Diagnostics Inc Company Snapshot
- Quest Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Quest Diagnostics Inc - Pipeline Analysis Overview
- Business Description
- Quest Diagnostics Inc - Key Facts
- Quest Diagnostics Inc - Major Products and Services
- Quest Diagnostics Inc Pipeline Products by Development Stage
- Quest Diagnostics Inc Ongoing Clinical Trials by Trial Status
- Quest Diagnostics Inc Pipeline Products Overview
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD)
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) Product Overview
- AD-Detect ABeta 42/40 and p-tau217 ApoE4 Evaluation Panel
- AD-Detect ABeta 42/40 and p-tau217 ApoE4 Evaluation Panel Product Overview
- AI-Enabled Computational Pathology - Solid Tumor
- AI-Enabled Computational Pathology - Solid Tumor Product Overview
- Biomarker Test - Genetic Disorders
- Biomarker Test - Genetic Disorders Product Overview
- Bromotyrosine Test
- Bromotyrosine Test Product Overview
- Cardio IQ KIF6 Genotype Test
- Cardio IQ KIF6 Genotype Test Product Overview
- Cardiovascular Mortality Prediction Test
- Cardiovascular Mortality Prediction Test Product Overview
- Diagnostic Assay - Colorectal Cancer
- Diagnostic Assay - Colorectal Cancer Product Overview
- Diagnostic Test - Influenza A H5 Virus
- Diagnostic Test - Influenza A H5 Virus Product Overview
- Genotyping Assay - Cystic Fibrosis
- Genotyping Assay - Cystic Fibrosis Product Overview
- Genotyping Assay - Fragile X Syndrome
- Genotyping Assay - Fragile X Syndrome Product Overview
- Haystack MRD Dx Test - Colorectal Cancer
- Haystack MRD Dx Test - Colorectal Cancer Product Overview
- Haystack MRD Dx Test - Colorectal Cancer Clinical Trial
- HDL Function Test
- HDL Function Test Product Overview
- LungDx
- LungDx Product Overview
- MRD Test - Breast Cancer
- MRD Test - Breast Cancer Product Overview
- MRD Test - Lung Cancer
- MRD Test - Lung Cancer Product Overview
- Multi-cancer Stratification (MCaST) Blood Test
- Multi-cancer Stratification (MCaST) Blood Test Product Overview
- Urine Biomarker Test - Prostate Cancer
- Urine Biomarker Test - Prostate Cancer Product Overview
- VeraMarker BCR Test - LDT
- VeraMarker BCR Test - LDT Product Overview
- ViroSeq HCV Assay
- ViroSeq HCV Assay Product Overview
- Quest Diagnostics Inc - Key Competitors
- Quest Diagnostics Inc - Key Employees
- Quest Diagnostics Inc - Key Employee Biographies
- Quest Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Quest Diagnostics Inc, Recent Developments
- Apr 21, 2026: Quest Diagnostics Reports First-Quarter 2026 Financial Results and Raises Full-Year Revenue and EPS Guidance
- Apr 16, 2026: City of Hope to Evaluate Quest Diagnostics' Haystack MRD for Guiding Patient Management in Multiple Cancers
- Apr 10, 2026: LabOne Receives CLIA Approval for Express Results Urine Drug Screen Cup
- Mar 12, 2026: Quest Diagnostics Elects Timothy Wentworth to Board of Directors
- Mar 02, 2026: Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results
- Feb 10, 2026: Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share
- Feb 03, 2026: Quest launches flow cytometry MRD test for myeloma
- Jan 22, 2026: LifeLabs Opens New Uptown New Westminster Patient Service Centre, Enhancing Access to Community-Based Diagnostic Care
- Jan 08, 2026: Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026
- Jan 06, 2026: Data Featuring Haystack MRD from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Quest Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Quest Diagnostics Inc Pipeline Products by Equipment Type
- Quest Diagnostics Inc Pipeline Products by Indication
- Quest Diagnostics Inc Ongoing Clinical Trials by Trial Status
- Quest Diagnostics Inc, Key Facts
- Quest Diagnostics Inc, Major Products and Services
- Quest Diagnostics Inc Number of Pipeline Products by Development Stage
- Quest Diagnostics Inc Pipeline Products Summary by Development Stage
- Quest Diagnostics Inc Ongoing Clinical Trials by Trial Status
- Quest Diagnostics Inc Ongoing Clinical Trials Summary
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) - Product Status
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) - Product Description
- AD-Detect ABeta 42/40 and p-tau217 ApoE4 Evaluation Panel - Product Status
- AD-Detect ABeta 42/40 and p-tau217 ApoE4 Evaluation Panel - Product Description
- AI-Enabled Computational Pathology - Solid Tumor - Product Status
- AI-Enabled Computational Pathology - Solid Tumor - Product Description
- Biomarker Test - Genetic Disorders - Product Status
- Biomarker Test - Genetic Disorders - Product Description
- Bromotyrosine Test - Product Status
- Bromotyrosine Test - Product Description
- Cardio IQ KIF6 Genotype Test - Product Status
- Cardio IQ KIF6 Genotype Test - Product Description
- Cardiovascular Mortality Prediction Test - Product Status
- Cardiovascular Mortality Prediction Test - Product Description
- Diagnostic Assay - Colorectal Cancer - Product Status
- Diagnostic Assay - Colorectal Cancer - Product Description
- Diagnostic Test - Influenza A H5 Virus - Product Status
- Diagnostic Test - Influenza A H5 Virus - Product Description
- Genotyping Assay - Cystic Fibrosis - Product Status
- Genotyping Assay - Cystic Fibrosis - Product Description
- Genotyping Assay - Fragile X Syndrome - Product Status
- Genotyping Assay - Fragile X Syndrome - Product Description
- Haystack MRD Dx Test - Colorectal Cancer - Product Status
- Haystack MRD Dx Test - Colorectal Cancer - Product Description
- Haystack MRD Dx Test - Colorectal Cancer - A Prospective Observational Cohort Study for Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients Undergoing Systemic Chemotherapy and Liver Resection with Curative Intent
- HDL Function Test - Product Status
- HDL Function Test - Product Description
- LungDx - Product Status
- LungDx - Product Description
- MRD Test - Breast Cancer - Product Status
- MRD Test - Breast Cancer - Product Description
- MRD Test - Lung Cancer - Product Status
- MRD Test - Lung Cancer - Product Description
- Multi-cancer Stratification (MCaST) Blood Test - Product Status
- Multi-cancer Stratification (MCaST) Blood Test - Product Description
- Urine Biomarker Test - Prostate Cancer - Product Status
- Urine Biomarker Test - Prostate Cancer - Product Description
- VeraMarker BCR Test - LDT - Product Status
- VeraMarker BCR Test - LDT - Product Description
- ViroSeq HCV Assay - Product Status
- ViroSeq HCV Assay - Product Description
- Quest Diagnostics Inc, Key Employees
- Quest Diagnostics Inc, Key Employee Biographies
- Quest Diagnostics Inc, Subsidiaries
- Quest Diagnostics Inc, Joint Venture
- Glossary
- Quest Diagnostics Inc Pipeline Products by Equipment Type
- Quest Diagnostics Inc Pipeline Products by Development Stage
- Quest Diagnostics Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- Celcuity Inc
- Nymox Pharmaceutical Corp
- Novant Health Inc
- Labcorp Holdings Inc
- Alere Inc
- Net Medical Xpress Solutions Inc
- Bio-Rad Laboratories Inc
- Personalis Inc
- Psychemedics Corp
- CapForce Inc
